Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
The Chinese University of Hong Kong and ConsenSys Announce the Medoxie COVID-19 Digital Health Passport
The Chinese University of Hong Kong (CUHK) along with ConsenSys, the leading Ethereum software company, […]
Kesimpta® (Ofatumumab) Data Show Long-term Preservation of IgG/IgM Levels and no Increased Risk of Serious Infections in People Living with Multiple Sclerosis
Today, Novartis disclosed new data showing mean IgG and IgM levels remain unchanged in adults […]
Remote Healthcare Market Size Worth $23.9B by 2028
The global remote healthcare market size is expected to reach USD 23.9 billion by 2028, according to a new report […]
Implantable Brain Device Relieves Pain in Early Study
A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study […]
Nuevocor Closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
Over One Million Jabs Booked as NHS Vaccine Programme Opens to All Adults
More than one million jab appointments were booked since the NHS vaccination programme opened for […]
NHS Kicks Off ‘CPR Army’ Following Footballer’s Collapse
England’s top doctor is sending out an army of volunteers to teach CPR after international […]
More than 30 Million People Vaccinated with Second Dose
More than 30 million people in the UK have been vaccinated with a second dose […]
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment
Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more